Business Segments · Goodwill
Oncology & Multispecialty — Goodwill
McKesson Oncology & Multispecialty — Goodwill increased by 0.6% to $3.95B in Q4 2025 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2025
Last reportedQ4 2025
Rolls up toGoodwill
How to read this metric
A stable or increasing balance suggests successful integration and sustained value, while a decrease may indicate impairment testing results.
Detailed definition
This metric represents the carrying value of goodwill allocated to the Oncology and Multispecialty segment, arising from...
Peer comparison
Standard balance sheet item for companies with significant M&A activity in the specialty pharmacy and healthcare services space.
Metric ID:
mck_segment_oncology_multispecialty_goodwillHistorical Data
3 periods
| Q1 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|
| Value | $2.72B | $3.93B | $3.95B |
| QoQ Change | — | +44.2% | +0.6% |
Range$2.72B – $3.95B
Current Streak2+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's oncology & multispecialty — goodwill?
- McKesson (MCK) reported oncology & multispecialty — goodwill of $3.95B in Q4 2025.
- What does oncology & multispecialty — goodwill mean?
- The total value of goodwill attributed to the Oncology and Multispecialty segment from past acquisitions.